UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): March 7, 2014 (March 5, 2014)
MYLAN INC.
(Exact Name of Registrant as Specified in Charter)
Pennsylvania | 1-9114 | 25-1211621 | ||
(State or Other Jurisdiction of Incorporation) |
(Commission File Number) |
(I.R.S. Employer Identification No.) |
1000 Mylan Boulevard Canonsburg, PA |
15317 | |
(Address of Principal Executive Offices) | (Zip Code) |
Registrants telephone number, including area code: (724) 514-1800
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
¨ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
¨ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
¨ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2 (b)) |
¨ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4 (c)) |
Item 5.02. Departure of Directors or Certain Officers.
On March 5, 2014 Mylan Inc. (Mylan or the Company) announced that Daniel C. Rizzo, Jr., Senior Vice President, Chief Accounting Officer, and Corporate Controller will cease to be the Chief Accounting Officer as of May 1, 2014 and will leave the Company as of July 1, 2014.
Mr. Rizzo joined Mylan in 2006, and has served the company with distinction and integrity throughout his tenure. Mr. Rizzo has been an important part of the leadership team that helped successfully transform Mylan from a U.S.-based generics business into a leading global pharmaceutical company. During his tenure, Mr. Rizzo also led Mylans global controllership team, including serving as our principal financial officer for a period of time.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
MYLAN INC. | ||||||||
Date: | March 7, 2014 | By: | /s/ John D. Sheehan | |||||
John D. Sheehan | ||||||||
Executive Vice President & Chief Financial Officer |